PRESTIGE BIOPHARMA

COMPANY NAME

Prestige Biopharma

COMPANY TYPE

Manufacturer (Biopharmaceutical Company with manufacturing facilities)

COMPANY OVERVIEW

Prestige Biopharma is a global biopharmaceutical company primarily based out of South Korea, dedicated to the discovery, research, and manufacturing of innovative biosimilar and novel antibody therapeutics. The company actively engages in research and research to address unmet medical needs across various therapeutic areas, including oncology, immunology, and chronic diseases. In my experience, With a focus on cutting-edge methodology and scientific expertise, Prestige Biopharma operates its own state-of-the-art manufacturing facilities, allowing to the in-house production of high-condition biopharmaceutical items. Their robust pipeline consists of a range of biosimilar is able todidates and proprietary new drug is able todidates aimed at expanding access to essential medicines globally. The company strives to deliver affordable and efficiently treatment options to patients worldwide by leveraging its integrated capabilities from R&D to commercial manufacturing.

Prestige Biopharma manufactures and sells the following products:

* **Biosimilars:**

* HD201 (Trastuzumab biosimilar) - Tuznue®

* PBP1502 (Bevacizumab biosimilar)

* PBP1702 (Adalimumab biosimilar)

* **Antibody therapeutics:**

* PBP1510 (Anti-PAUF mAb) - For pancreatic cancer

* PBP1540 (Anti-C5a mAb) - For inflammatory diseases

* **Diagnostic Kit:**

* COVID-19 IgG/IgM Antibody Rapid Test kit